Karyopharm Therapeutics Inc.
KPTI· Nasdaq
Karyopharm Therapeutics Inc.
- Last sale
- Oct 1, 2026 · -27.71%
- Market cap
- $19.84M
- 22.68M shares
- Filings
- 1,022
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $146,067,000 | reported | |
| FY 2024 | 2024-12-31 | $145,237,000 | reported | |
| FY 2023 | 2023-12-31 | $146,033,000 | reported | |
| FY 2022 | 2022-12-31 | $157,074,000 | reported | |
| FY 2021 | 2021-12-31 | $209,819,000 | reported | |
| FY 2020 | 2020-12-31 | $108,085,000 | reported | |
| FY 2019 | 2019-12-31 | $40,893,000 | reported | |
| FY 2018 | 2018-12-31 | $30,336,000 | reported | |
| FY 2017 | 2017-12-31 | $1,605,000 | reported | |
| FY 2016 | 2016-12-31 | $154,000 | reported | |
| FY 2015 | 2015-12-31 | $250,000 | reported | |
| FY 2014 | 2014-12-31 | $229,000 | reported |
Karyopharm Therapeutics Inc. · CIK 1503802 · Engraved from SEC EDGAR
